Hepatocellular carcinoma in the world and the middle East
- PMID: 25197510
- PMCID: PMC4154905
Hepatocellular carcinoma in the world and the middle East
Abstract
Hepatocellular carcinoma (HCC) is a major worldwide public health concern. Despite recent advances, there has been little success in improving the survival of HCC patients. Due to advances in diagnostic modalities and the increasing incidence of chronic viral hepatitis and nonalcoholic fatty liver disease (NAFLD), both of which are well known risk factors of HCC, the prevalence of HCC is increasing in developed countries and it is expected that this trend will continue in the future. In Middle Eastern countries the prevalence of this cancer is lower compared to sub-Saharan Africa and some Far East countries; however it is documented that the prevalence of this cancer in some parts of the Middle East is also increasing. In the current review, the prevalence and burden of this disease worldwide, particularly in Middle Eastern countries, and risk factors for HCC are discussed.
Keywords: Chronic Hepatitis; Hepatocellular Carcinoma; Prevalence; Viral Hepatitis.
References
-
- Ferlay J BF, Pisani P. Globocan 2000: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, IARC Nonserial Publication, 2001.
-
- Kirk GD, Bah E, Montesano R. Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis. 2006;27:2070–82. - PubMed
-
- Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000The global picture. Eur J Cancer. 2001;37:S4–66. - PubMed
-
- Okuda K, Tabor G. Liver Cancer. New York: Churchill Livingstone; 1997.
-
- Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533–43. - PubMed
Publication types
LinkOut - more resources
Full Text Sources